Меню
Идёт набор NCT07663539

Insights From Bereaved Parents and Oncologists

Наблюдательное Communication

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально
Состояния в реестре: Communication. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Foundations of Communication in Uncertainty Study (FOCUS): Insights From Bereaved Parents and Oncologists

Обзор

Investigators want to find better ways for doctors and families to talk about cancer and how uncertainty may affect a child's life.

Подробное описание

Primary Objective

* To characterize how bereaved parents of children with cancer and their child's oncologist perceive their experience with communication about prognostic uncertainty during the child's cancer journey and during bereavement.

Secondary Objective

* To elicit parents' and oncologists' preferences and recommendations for how clinicians should talk with children and families about prognosis in the setting of uncertainty.

This study aims to explore bereaved parents' and oncologists' reflections on communication about prognostic uncertainty during the child's cancer treatment. Parents who have lost a child to cancer and the doctors who treated them will be invited to join this study.

Participants who opt to participate in the study will engage in an audio recorded semi-structured interview with a researcher, virtually or in person (at their discretion) to share their perspectives and recommendations based on their experience. Throughout the interview, the interviewer has the option to ask additional questions (i.e., probe with questions not in the interview guide) to respond to comments made by the participant and honor the topics of interest to that given participant. The participant will be provided an opportunity to add any details or comments at the end of the interview if he/she would like to share additional information.

Following completion of the qualitative portion of the interview, the researcher will ask the participant several questions from a demographic form. The demographic form will include questions related to participant age, race/ethnicity, state/country of residence for bereaved parents, and years of clinical practice for oncologists.

Первичные конечные точки

  • Bereaved parents of children with cancer and oncologists reflections on communication about prognostic uncertainty during the child's cancer treatment [Срок оценки: Approximately 1-3 weeks after enrollment.]

Критерии участия

Критерии включения

  • All participants must be ≥ 18 years of age or legally emancipated
  • Parent Participants must have a child who:
  • Received cancer care from a clinician at St. Jude, as documented in the electronic medical record, AND
  • Died at least 6 months prior to enrollment, but no more than 24 months prior to enrollment.
  • Oncologist participants at St. Jude must:
  • Be listed as the primary oncologist as documented in the electronic medical record, AND
  • Have the respective patient's parent agreement to participate in the study.

Критерии исключения

  • Declining, refusal, or unwillingness to participate
  • Inability or unwillingness of research participant to give informed consent.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

США · 1 центр
  • St. Jude Children's Research Hospital — Memphis

Идентификаторы

NCT: NCT07663539 · FOCUS · NCI-2026-05231

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗